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Abstract  
Background: The optimal age for introducing complementary feeding to breast-fed infants may 
differ depending on the setting. Prolonged exclusive breastfeeding (EBF) protects against 
infection but may increase the risk of iron deficiency (ID)/anaemia (IDA) in vulnerable infants.  
Aim: To compare haemoglobin (Hb), serum ferritin (SF)), anaemia (Hb<11g/l), ID (SF <12µg/l) 
and IDA (Hb<10.5g/dl+Hct<33%+ID) using observational analyses in 6-month old infants from 
Bogota, Colombia who were EBF for 4-5 versus ≥6 months; and examine predictors. 
Methods: Infant feeding was recorded, anthropometry performed and blood obtained for Hb 
and SF at 6 months in healthy term infants (birth weight>2500g), all EBF for ≥4 months. 
Results: 108 infants (54% boys) were recruited; 46% EBF for 4-5mo, 54% EBF at 6mo. 
Prevalence of anaemia, ID and IDA was 20%, 10% and 5%, with no significant difference 
between EBF4-5 and EBF6 groups.  In multivariate models, anaemia/ID were predicted by 
greater weight gain from 0-6 mo, and anaemia also by caesarean delivery; Hb was lower in 
infants with higher intake of cows’ milk; SF was lower in boys and those with greater weight 
gain. EBF4-5 versus EBF6 was not a significant predictor of any outcome.  
Conclusion: Anaemia and ID were common at 6 months but were not affected by EBF for 4-5 
versus 6 months, suggesting 6 months EBF is safe in this population. However, further 
research is required to examine effects on later iron status. The findings highlight the need to 
emphasise avoidance of cow´s milk before 12 months. Word count 241 
Key words: exclusive breastfeeding, growth, iron status, cows’ milk 
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What is known 
 The World Health Organisation (WHO) recommends exclusively breastfeeding (EBF) 
for 6 months 
 This protects against infection but may be associated with greater risk of iron deficiency 
(ID) and iron deficiency anaemia (IDA) 
What is new 
 20% of healthy term infants from Bogota were anaemic at 6 months, although only 5% 
had IDA 
 EBF for 4-5 versus 6 months did not influence anaemia, ID, IDA or haemoglobin/serum 
ferritin 
 Modifiable predictors of Hb/ anaemia were higher cow´s milk intake, highlighting the 
need to strengthen recommendations to avoid cow´s milk before 12 months and 
caesarean delivery, which may be related to earlier cord clamping 
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Introduction 
The World Health Organisation (WHO) recommends that infants should be exclusively breast-
fed (EBF) for 6 months, followed by the introduction of complementary foods (CF) alongside 
continued breastfeeding [1-3]; however in most settings, CFs are frequently introduced before 
6 months of age[4]. The WHO recommendation was based on the findings of a systematic 
review and expert consultation which concluded that infants EBF for 6 months rather than 3-
4 months had a significantly lower risk of gastrointestinal infection, together with potential 
benefits for the mother in terms of delayed return of menses and faster post-partum weight 
loss. However, 6 months EBF was also associated with an increased risk of iron deficiency 
(ID) and iron deficiency anaemia (IDA) in vulnerable infants studied in a RCT in Honduras [1, 
3, 5]. Other observational studies not eligible for the WHO review, including several in higher 
income settings, have also suggested that relatively longer periods of EBF are protective 
against gastrointestinal, ear and respiratory infections, and against hospitalisation for infection 
[6-10], whilst infants with more prolonged EBF have also been reported to be at greater risk 
of ID and IDA later in infancy [11, 12]. The only recent RCT to compare infant iron status with 
4 versus 6 months of EBF, conducted in Iceland, reported significantly higher serum ferritin 
(SF) concentrations at 6 months with earlier introduction of CF, although all infants in this low 
risk population had SF within the expected range and none were ID or had IDA [13]. 
Collectively, these data suggest that the optimal duration of EBF may be different depending 
on the setting and balance of risks and benefits. 
 
The primary aim of our study was to compare measures of iron status (Hb, SF), Anaemia, ID 
and IDA at 6 months of age in infants EBF for 4-5 versus ≥6 months (EBF4-5 versus EBF6), 
from deprived areas of Bogota, Colombia where the prevalence of anaemia (defined as 
Hb<11g/dL) measured between 6 and 11 months is high ((59.7%), ENSIN 2010[4]. The 
secondary aim was to determine predictors of iron status in this population. 
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Methods 
Subjects and study design 
Healthy term infants with birth weight>2500g were recruited from the growth monitoring 
programme at Suba and Fontibon hospitals in Bogota, Colombia. Both are Baby Friendly 
hospitals covering a population with low socioeconomic status. Family incomes come mainly 
from informal and part-time jobs. Most families live in rented or shared households with public 
service coverage including tap water, electricity and waste disposal. Approximately 29% of 
families experience food insecurity (ENSIN 2010) [4].  
Mothers who were EBF at 4 months were approached and invited to participate in a 
randomised control trial (ISRCTN57733004)of standard versus new complementary feeding 
guidelines, starting at 6 months [14]. All mothers were advised to EBF until 6 months. 108 
mothers who met the inclusion criteria and who were willing to participate were recruited at 6 
months, and gave written informed consent. A non-fasting morning blood sample (<5mL) was 
collected by venepuncture at 6 months. Data on iron status, anthropometry and food intake 
was collected from all infants; anaemic infants (defined as Hb<11g/dL according to local 
practice) were treated and were not included in the RCT although their data were used in this 
observational analysis (Figure 1). The study was approved by research ethics committees at 
University College London and Pontificia Universidad Javeriana, Bogota, Colombia. 
 
Biochemical measurements: Measurements of Haemoglobin (Hb; using spectrophotometry), 
Haematocrit (Hct), mean cell volume (MCV; using automated flow cytometry), C-reactive 
protein (CRP;using two-site enzyme-linked immune-absorbent assay (ADALTIS-Dizar)) were 
performed within 24 hours, and samples for SF (measured using two-site enzyme linked 
immune-absorbent assay ELISA (DALTIS-Dizar)) were stored at <20ºC prior to analysis. 
CRP was used as a biomarker of inflammation; infants with values >6mg/l were excluded. 
The following cut-offs recommended by WHO were used:  Hb<11g/dL, Hct<33%, 
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SF<12µg/l[15], MCV < 70fl[15]. Anaemia was defined as Hb<11g/dL, and ID as SF<12μg/L. 
IDA was defined as Hb<11.0g/dL+Hct<33%+SF <12µg/L (WHO); results using other 
definitions are provided for comparison [16-18]. We also performed analyses using an 
altitude-adjusted value of 12.3g/dL for Hb and 37% for Hct as recommended by WHO, since 
Bogota lies at an altitude of 2,600m [15, 19].  
 
Anthropometric measurements: Birth weight and length at birth were collected from medical 
records. At 6 months length was measured using an infantometer with fixed headboard and 
movable footboard, to the nearest 1mm (mean of 3 measurements). Infants were weighed 
naked on an electronic scale (Tanita). Results were converted to SD scores using WHO 
growth standard data[20]. 
 
Assessment of infant feeding: Exclusivity of breastfeeding was defined using a strict definition 
covering the whole of the first six months as follows: i) exclusive breastfeeding: infant has 
received only breast milk without any other food, liquids or supplements and ii) complementary 
feeding: infant has received solid and liquid foods other than breast milk including other milks 
such as infant formula, follow on formula and cow’s milk.  
 
At 6 months, infant feeding was recorded using a semi-quantitative food frequency 
questionnaire (FFQ) and a 24 hour recall. The FFQ included a table on which the researcher 
recorded information based on the intake of 8 selected Colombian food groups. Mothers were 
asked the number of times, and number of portions per day, week, or month that each food 
was consumed during the last month. If the infant had never consumed the food it was 
recorded as 'never'.  Foods were then defined as being consumed daily, weekly or monthly. 
 
A 24 hour recall was also applied. Mothers described all foods consumed by the infant 
in the last 24 hours. To estimate nutrient intakes, the amount of each food (as tablespoon, 
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cup, etc) was manually converted into grams or ml consumed per day based on standardized 
measures previously calculated[21], and data were entered into a spreadsheet (Excel) that 
included information on the nutrient content of 208 foods provided by Colombian Food 
Composition Tables, USDA National Nutrient Database for Standard Reference, food labels 
(infant food) and manufacturers’ information for formula milk[22] 
 
Daily breast milk intake was estimated using an algorithm based on published data[23], 
and taking into account our previous unpublished data and the information recorded in the 24 
hour recall on (i) number of breastfeeds/day, (ii) duration of each breast feed, (iii) number of 
breastfeeds per night and (iv) infant appetite. Nutrient intakes from breast milk were estimated 
using Colombian Food Composition Table data and the USDA National Nutrient Database for 
Standard Reference; assuming 70Kcal/100ml for energy and 0.03mg/100ml for iron. 
 
Statistics 
Sample size: The target sample size for the RCT was 64 infants per group [14].However, this 
sample size could not be achieved within the time-frame of the study, mainly because the 
prevalence of EBF in Bogota had fallen, reducing the number of eligible infants. 108 mothers 
who met the inclusion criteria were recruited at 6 months. For the current analyses, infants 
were grouped according to the duration of EBF: 4-5 months (EBF4-5) or ≥6 months EBF 
(EBF6).  
Data Analyses were performed using SPSS version 18. In the primary analyses, indicators of 
iron status and growth were compared between the EBF4-5and EBF6 groups using t-test, 
Mann-Whitney or chi-square test. Secondary analyses were performed to explore predictors 
of iron status at 6 months and to adjust for potential confounders. Correlations between 
potential predictors of iron status were first examined and significant factors included in 
multivariate regression models. Gestational age, gender, birth weight ≤/>3 kg, and mode of 
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delivery were included in all models as these variables have been reported to be significant 
predictors of iron status in other studies. Other potential predictors considered were 
anthropometric measures (LAZ 6mo, WLZ 0-6 mo, WAZ 0-6 mo), intake of complementary 
foods (such as meat, fruit, vegetable, milk (infant formula, cows milk) egg, legumes) and 
estimated energy, protein, fat, carbohydrate, iron and zinc intakes from breast milk and 
complementary foods. Logistic regression was used to determine predictors of anaemia and 
ID. It was not possible to examine predictors of IDA due to the small number of affected infants. 
Linear regression models were used to examine predictors of Hb/SF. SF concentrations and 
cow´s milk consumption were not normally distributed and were therefore log transformed for 
analysis. 
 
Results 
Figure 1 shows the study design. Infants attended for the screening blood test at 6 months 
and outcomes reported in this paper were also measured at 6 months, within one week of the 
blood test. Fifty six (52%) of the infants were EBF at 6 months (EBF6) and 52 (48%) were 
exclusively breast-fed for 4-5 months (EBF4-5 infants). Nineteen of the EBF4-5 infants 
received CF between 4 and 5 monthsand 33 received CF between 5 and 6 months.  3 infants 
received a small amount of CF (fruit juice) on the day before the study visit; it was considered 
that this could not have altered their iron status and therefore they were included in the EBF6 
group. There was no significant difference between groups in gestational age, delivery mode, 
birth weight or socio-economic characteristics (Table 1).  EBF6 mothers were significantly 
older whilst a significantly higher proportion of the EBF4-5 group were boys.  
 
Anaemia and Iron status 
The proportion of infants with Hb<11g/dL in this population was high – 20% of all infants - but 
it was not significantly different between groups (11 (21.2%) for EBF4-5 and 11 (19.6%) for 
EBF6). Adjusting for altitude resulted in an increase in the proportion of infants with anaemia 
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to 67.3% and 69.6% respectively, but still with no significant difference between groups.  Four 
(8.2%) of EBF4-5 and 6 (12.8%) of EBF6 infants had ID (SF< 12µg/L; Table 2). The number 
and proportion of infants with IDA was 5.1%. The prevalence of IDA did not differ significantly 
between groups and was similar when alternative definitions were used and when Hb was 
adjusted for altitude (Table 2).There were no significant differences in Hb, Hct, MCV or SF 
between EBF4-5 versus EBF6 groups (Table 2); nor when further sub-divided into those EBF 
for 4, 5 and ≥6 months (see supplemental digital content Table S1). 
 
Growth  
There was no significant difference in WAZ, WLZ, or LAZ at 6 months, or in the change in 
WAZ or LAZ from 0-6 months between EBF4-5 and EBF6 infants (See supplemental digital 
content Table S2). The proportion of EBF4-5 and EBF6 infants with LAZ < -2 SD at 6 months 
was not significantly different although a greater proportion of boys had LAZ <- 2SD (12 
(21.4%) versus 1 (2.0%) girl, p=0.002).  There was no significant difference between EBF4-5 
and EBF6 groups in the proportion with WAZ <-2SD (2 (3.8%) versus 2 (3.6%), p=0.9). 
 
Breastfeeding practices 
EBF6 infants had a significantly higher mean number of breastfeeds/day (7 (SD2) versus 6 
(SD2), p=0.02) and higher estimated breast milk intake/day (830 ml (143) versus 714 ml (136), 
p<0.001) than EBF4-5 infants. The estimated average breast milk intake was 94ml/kg body 
weight in EBF4-5mo and 109 ml/kg body weight in EBF6 infants at 6 months of age. There 
was no significant difference in the number of night-time breastfeeds (EBF4-5 2 (1) versus 
EBF6 2 (1)). 
 
Complementary feeding 
There was no significant difference between EBF4-5 and EBF6 in estimated total energy 
intake (630 (SD83) Kcal/day versus 600 (94) Kcal/day, (95% CI -7 to 62), p=0.12). CFs in the 
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Dietary records were available for 51 infants in the EBF4-5 group (18 EBF for 4 mo, 33 EBF 
for 5 mo). CF provided an estimated 128 ((98) Kcal/day, 20% of total energy intake), 4.6 (3.9) 
g/day protein (39.3% of intake), and 1.09 (1.1) mg/d of iron (80.4 % of intake). 13.7% (7/51) 
of EBF4-5 infants received infant formula, 17.6% (9/51) follow on formula and 39% (20/51) 
(non-fortified)cow´s milk, with a reported weekly frequency of consumption of 1.0 (2.9), 1.0 
(2.6) and 2.0 (3.7)times/week and mean daily intake of 137ml (119), 149ml (139) and 85ml 
(112), respectively.  The main sources of iron in EBF4-5 infants were infant formula 
(1.03mg/day), received by 14% (7/51); infant cereal (0.78 mg/day), received by 23.5% (12/51); 
follow on formula (0.76mg/day) received by 17.6% (9/51), and red meat (0.73mg/day) received 
by 17.6% (9/51). EBF4-5 infants had significantly higher estimated total iron intake than EBF6 
infants (1.35mg/d (1.1) versus 0.32mg/d (0.07), p=<0.001), of which 1.1 (1.1) mg/day came 
from complementary foods, while EBF6 infants had significantly higher iron intake from breast 
milk (0.32mg (0.06) versus 0.27 (0.06), p<0.001).  
 
Predictors of anaemia and ID 
Logistic regression models included (i) EBF4-5 v EBF6; (ii) independent variables found to be 
associated with anaemia or ID in univariate analyses in this study (for anaemia; sex (r=0.193, 
p=0.045), change in WLZ 0 to 6mo (r=-0.259, p=0.007), mode of delivery (r=-0.203,p=0.036) 
and LAZ at 6mo (r=-0.228, p=0.019): for ID; change in WAZ 0 to 6mo (-0.217, p=0.031)): (iii) 
other variables reported to be related to these outcomes in previous studies (for anaemia; 
gestational age and birthweight ≤/>3kg: for ID; sex, mode of delivery, gestational age, 
birthweight ≤/>3kg). The significant predictors of anaemia were mode of delivery (higher risk 
in infants delivered by caesarean section compared to vaginal delivery, β=1.29, OR 3.7 (95% 
CI 1.16 to 11.4), p=0.027)) and change in WLZ from 0 to 6 months (β=0.47, OR 1.6 (95%CI 
1.14 to 2.24), p= 0.007)). ID was predicted by change in WAZ from 0 to 6 months (β= 0.59, 
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OR 2.6 (95% CI 1.13 to 5.97), p=0.02)). Anaemia and ID in this cohort were not predicted by 
the age of introduction of CF. 
 
Predictors of Hb and SF 
In univariate analyses, Hb at 6 months was significantly and negatively correlated with daily 
intake of protein (r=-0.29, p=0.003), fat (r=-0.23, p=0.02), zinc (r=-0.25, p=0.01), cow´s milk 
ml/day (r=-0.58, p=0.01); and with positive change in WLZ from 0 to 6 mo (r=-0.21, p=0.03).  
SF was negatively correlated with weight at 6mo (r=-0.23, p=0.02), and with change in WAZ 
from 0 to 6mo (r=-0.295, p=0.003). There were no significant correlations between indicators 
of iron status and other dietary variables. Stepwise multiple regression models were used to 
identify predictors of Hb and SF. Intake of cow’s milk ml/day was a negative predictor of Hb. 
SF was negatively predicted by the change in WAZ from 0 to 6mo and positively by female 
sex (Table S3).  
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Discussion 
In this population of infants living in poor socioeconomic conditions in Bogota, Colombia, 
where 59% of infants are anaemic and 24% ID at 1 year of age despite existing 
supplementation policies (ENSIN 2010)[4], we found a high prevalence of anaemia and ID 
even at 6 months. 20% of the infants had Hb< 11g/dl, the cut-off used routinely in Bogota, and 
10.4% had ID, although only 25% of the anaemia was attributable to ID. Indicators of iron 
status (Hb, SF) and the prevalence of anaemia, ID or IDA were not influenced by whether 
complementary foods had been introduced alongside breastfeeding from 4 months or delayed 
until 6 months. Our findings suggest that EBF for 6 months is safe, even in this high-risk 
population, in terms of the prevalence of ID and IDA at 6 months of age, although effects on 
iron status beyond this age need to be determined.  
 
The optimal duration of EBF has been a topic of much discussion, particularly in relation to 
short-term health effects on infection risk, allergy risk and ID. More prolonged EBF has 
beneficial effects on the risk of gastrointestinal and respiratory tract infections, including risk 
of hospitalisation for infection, even for infants in higher income countries. However, it is 
uncertain whether 6 months EBF is adequate in terms of providing sufficient iron to ensure 
adequate iron status for all infants, particularly those with poor iron stores at birth. This is of 
concern given irreversible adverse effects of ID and IDA on brain development [24, 25]. A RCT 
in Honduras using iron-fortified commercial baby foods reported significantly lower Hb in 
infants EBF for 6 months without iron supplements (10.4 (0.1)) than in infants who received 
CF (10.9 (0.1)) [5]. In another trial, Icelandic infants randomised to receive CF from 4 months 
had significantly higher SF at 6 months (70.0 (73.3) µg/L)) than infants EBF for 6 months (44.0 
(53.8)µg/L)), although both groups in this low-risk population had SF within the normal 
range[13]. Observational studies have also reported that more prolonged EBF is associated 
with an increased risk of anaemia later in infancy. In a retrospective analysis of data from a 
study comparing German infants who were fully BF for 4 months with those fed iron-fortified 
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formula, the prevalence of ID/IDA in BF infants was 19%/4%and 21%/2% at 7 and 10 months 
respectively; formula-fed infants had normal iron status at both ages. At 7 months, infants from 
the breast milk group also had lower Hb (11.4 g/dl versus 12.1g/dl) compared with formula fed 
infants [12] Similar results were found in a cross sectional survey of infants aged 6-24 months 
in the US (NHANES III), in which the proportion with a reported history of anaemia was 
significantly higher in infants fully BF for 6months (10%) than in those fully BF for 4-5 months 
(2.3%, p=0.007) [11]. 
 
In our study, infants in the EBF4-5 group received an estimated 1.35mg/day of iron per day 
with 1.09mg/day coming from CFs, while the EBF6 group received only 0.32mg/day from 
breast milk. Neither group met recommended intakes for iron (DRI EAR 6.9mg/day, RDA 
11mg/day from 6-8 months[26], WHO RDA 9.3mg/d[15]), although it should be noted that 6 
months is the lower end of the range for these recommendations, and occurs at around the 
time that infant iron stores from birth are likely to be exhausted and an alternative supply 
required. Nevertheless, it is clear that to achieve the recommended intakes in a short period 
of time would require a significant amount of either iron-rich or iron-fortified CF, or 
supplementation. The main sources of iron in the EBF4-5 group were infant formula, infant 
cereals, follow on formula, and red meat, with the latter contributing approximately 10% of 
total iron intake. However, the small amount of these CFs consumed may have displaced 
breast milk without contributing significant amounts of bioavailable iron, which may explain the 
lack of effect on iron status. Furthermore, 63% of the EBF4-5 group started CF during the 
5thmonth which may have blunted differences in iron intake and consequently iron status.  
 
Consistent with previous studies in slightly older infants, we found that cow´s milk consumption 
was a negative predictor of Hb. Soh [27] reported that cow’s milk consumption >500ml/day in 
infants less than 1 year of age was negatively related to Hb levels, probably due to 
displacement of iron-rich foods.  Similar results were reported in the ALSPAC study, where 
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infants were categorised according to the type of milk received, with the cow´s milk group 
divided by intake (<600 and >600ml); a higher proportion of anaemic infants were identified in 
the cow´s milk (28%) and breast milk (32%) groups compared with those receiving formula 
[28]. The estimated mean daily intake from cow’s milk in the 6 month old infants in our study 
was much lower at 85ml/day, and it seems more likely that the adverse association with Hb 
may be due to blood loss related to gastrointestinal bleeding[29]. Surprisingly, almost 39% of 
the infants in our EBF4-5 group were receiving cow’s milk, despite that fact that it is not 
recommended for infants less than 12 months in Colombia. This is clearly an area which 
requires further attention in terms of educational messages. Indeed, we previously reported 
that the new CF guidelines tested in this trial, which included advice to avoid cow’s milk as the 
main drink, resulted in reduced cow’s milk intake at 12 months and higher Hb[14].   
 
Anaemia was common in our population despite the fact that all were born at term, with birth 
weight above 2.5kg and EBF for at least 4 months. However, the prevalence of IDA was lower 
at 5%. The cause of anaemia not attributable to ID is unclear, although our results are very 
similar to those reported by Yang et al [18] in fully breast-fed Mexican infants at 6 months of 
age. Potential explanations include deficiencies of other nutrients such as vitamin A or B12; 
both of which are plausible in this population [4].  Haemoglobinopathies and chronic infection 
may also be a factor in other settings but are not likely explanations in our study population.  
Both anaemia and ID were predicted by relatively greater weight gain from birth to 6 months, 
consistent with other studies that have reported a higher risk of iron deficiency in infants with 
the most rapid growth[17,18]. Anaemia was also associated with the mode of delivery, with a 
higher risk in infants born by caesarean session. This may be due to earlier umbilical cord 
clamping following surgical delivery resulting in lower Hb and infant iron stores at birth. 
Delayed umbilical cord clamping has been shown to improve infant iron status in RCTs in both 
Mexico and Sweden [30, 31].ID was also higher in boys, consistent with several published 
studies suggesting that male infants are at greater risk.  
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Using an adjusted Hb cut-off of 12.3g/dl, given the high altitude of Bogota, the proportion of 
anaemic infants increased almost three fold, which seems implausible for a group of 
apparently healthy infants. To our knowledge, there are no published data on associations 
between Hb at 6 months and later brain development at different altitudes. However, in a large 
clinical trial in young children treated for WHO-defined severe pneumonia across 8 sites in 7 
low-resource countries [32], children at high altitude (>2000m) presented with significantly 
more severe hypoxemia and cyanosis than children at low altitude and took longer to recover 
from hypoxemia. Importantly, children with anaemia (defined as Hb<11g/dl) at high altitude 
had a significantly increased risk of poor outcome. This suggests that the combination of 
anaemia and high altitude is of particular concern and that a higher cut-off for Hb may well be 
appropriate in these settings. 
 
The major strength of our study is the availability of dietary intake data which allowed us to 
examine associations with iron status. However, the study had a number of limitations 
including the observational design and the relatively small sample size which meant that we 
were not able to examine predictors of IDA in logistic regression models. In addition, we were 
not able to measure other markers of iron status, or to examine the prevalence of ID/IDA later 
in infancy, since anaemic infants were treated and were not enrolled in the subsequent RCT. 
Data on the timing of cord clamping were not available thus we cannot establish that this was 
responsible for the association between mode of delivery and risk of anaemia. 
 
Conclusion 
Healthy term, normal birth weight infants from Bogota, all EBF for at least 4 months, had a 
high prevalence of anaemia at 6 months; 20% of the infants had Hb< 11g/dl and 10% were 
ID, although only 25% of anaemia was attributable to ID, suggesting that other factors such 
as Vitamin A or vitamin B12 may be important. Indicators of iron status and prevalence of 
anaemia, ID and IDA were not influenced by the introduction of CF between 4-5 and 6 months 
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alongside breastfeeding. This suggests that 6 months EBF is safe in terms of iron status at 
age 6 months in this population, although effects on later iron status were not investigated.  
 
Anaemia and ID were more common in faster growing infants, and anaemia was more 
common in infants delivered by Caesarean section. The latter finding may relate to the 
timing of clamping of the umbilical cord, but this information was not available in our study 
and further studies exploring time of cord clamping and other possible risk factors in infants 
born by CS are warranted. The intake of cow´s milk was negatively associated with Hb, 
highlighting the need to strengthen the recommendation to avoid cow´s milk in the first year 
of life and to make sure this message is delivered before 6 months. Further research is 
required to define the most ‘appropriate’ infant Hb cut-offs for anaemia in infants living at 
high altitudes, preferably relating proposed cut-offs to clinical outcomes such as cognitive 
development and morbidity from respiratory infection, and to identify other factors 
contributing to anaemia in this population. 
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Figure 1 legend. Flow diagram of study 
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Figure 1. Flow Diagram of study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Assessed for eligibility (n=353) at 4 months 
Excluded (n=185) 
 Did not meet inclusion criteria (n=102) 
 Declined to participate (n=60) 
 Other reasons (n=23) 
 168 Infants met inclusion criteria 
    EBF 4-5 months (n=52)      EBF 6 months (n=56) 
Enrolment at 6 months 
Analyzed (n=52) 
Growth (n=52) 
FFQ (n=50) 
24h recalls (n=51) 
Haemoglobin (n=52) 
Ferritin (n=50) 
 
Analyzed (n=56) 
Growth (n=56) 
FFQ (n=55) 
24h recalls (n=53) 
Haemoglobin (n=56) 
Ferritin (n=48) 
CF Group 
Analysis at 
6 months 
EBF Group 
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Table 1.  Baseline characteristics of mothers and infants in the study according to the 
duration of EBF 
Variable EBF4-5 
(n=52) 
EBF6 (n=56) p value 
Female n (%) 18 (35) 32 (57) 0.02* 
Male n (%) 34 (65) 24 (43)  
Gestational age Wks (SD) 39.1 (0.94) 39.1 (1.1) 0.92 
Birth weight g (SD) 3106 (340) 3063 (336) 0.51 
Birth Length cm (SD) 50.0 (1.7) 49.9 (1.9) 0.82 
Head circumference cm (SD) 34.0 (1.4) 33.8 (1.1) 0.41 
WAZ at birth 
WLZ at birth 
LAZ at birth  
HCZ at birth 
-0.45 (0.71) 
-0.92(1.21)  
 0.20 (0.96) 
-0.15 (1.1) 
-0.50(0.72) 
-1.04 (0.90) 
0.25 (1.0) 
-0.27 (0.89) 
0.75 
0.56 
0.83 
0.62 
Mother’s age years (SD) 22.5  (5.8) 25.0 (6.5) 0.04 
Father’s age years (SD) 26.6 (8.4) 27.7 (8.3) 0.52 
Family size n (SD) 5.5 (2.1) 5.0 (1.5) 0.17 
# children n (SD) 1.5 (0.6) 1.6 (0.8) 0.40 
# rooms in the house n (SD) 2.4 (1.0) 2.4 (1.2) 0.94 
Mother finished high school n (%) 
Birth weight < 3Kg 
Mode of delivery 
Caesarean n (%) 
Vaginal n (%) 
30 (59) 
21 (40) 
 
14 (27) 
38 (73) 
29 (53) 
25 (45) 
 
17 (31) 
38 (69) 
0.12* 
0.66 
 
 
0.65* 
EBF= Exclusive breastfeeding; LAZ= length for age z score; WAZ= weight for age z score, WLZ= weight for 
length z score; HCZ= head for age z score. Wks= weeks. P values from Student’s t-test unless indicated; *p<0.05 
by Pearson chi square; SD= Standard Deviation 
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Table 2.  Anaemia, ID, IDA and measures of iron status at 6 months in infants 
EBF for 4-5mo versus 6mo 
Variable EBF4-5  
n     Mean (SD) 
EBF6 
n    Mean (SD) 
Mean Difference 
(95% CI)               p value* 
 
Hb (g/dL) 
Hct (%) 
MCV (fL) 
Ferritin (µg/L) 
 
52   11.7 (1.0) 
52    34.6 (2.4) 
51    70.6 (4.0) 
50    35.7 (30.3) 
 
 
56    11.7 (1.0) 
56     34.9 (2.5) 
55     71.0 (3.9) 
48     40.6 (34.6) 
 
 
-0.04 (-0.43 to 0.35)   0.84 
-0.35 (-1.28 to 0.59)   0.47 
-0.37 (-1.89 to 1.16)   0.64 
-4.95 (-18.0 to 8.09)   0.45 
 n (%)  n (%)  Total n (%) p value** 
Anaemia (Hb<11g/dL) 
Anaemia (Hb<12.3g/dL) 
Iron Deficiency (SF<12µg/L) 
11 (21.2) 
35 (67.3) 
4 (8.2) 
11 (19.6) 
39 (69.6) 
6 (12.8) 
22 (20.4) 
74 (68.5) 
10 (10.4) 
0.85 
0.79 
0.46 
IDA1  (WHO,2001) 2 (4.0) 3 (6.3) 5 (5.1) 0.61 
IDA2  (Domellof ,2002) 2 (4.1) 2 (4.3) 4 (4.2) 0.96 
IDA3  (Thorisdottir, 2003) 2 (4.1) 3 (6.4) 5 (5.2) 0.61 
IDA4 (Yang, 2009) 2 (4.0) 3 (6.3) 5 (5.1) 0.61 
IDA adjusted for altitude     
IDA1  (WHO,2001) 2 (4.0) 3 (6.3) 5 (5.1) 0.61 
IDA2  (Domellof ,2002) 2 (4.1) 3 (6.4) 5 (5.2) 0.61 
IDA3  (Thorisdottir, 2003) 3 (6.1) 4 (8.7) 7 (7.4) 0.63 
IDA4 (Yang, 2009) 3 (6.0) 6 (12.5) 9 (9.2) 0.26 
Hb= haemoglobin; Hct= haematocrit; MCV= mean corpuscular volume. SF= serum ferritin (log transformed) 
EBF= exclusive breastfeeding.  
SD= Standard Deviation, *P<0.05 (T test), 95% CI (confidence interval), **P<0.05 (Pearson chi square) 
1. WHO (2001)  6 to 59 months: definition Hb<11.0g/dL+Hct<33%+SF <12µg/L 
2. Domellof  (2002) 6 months: definition Hb10.5 g/dL + SF <9µg/L + MCV <71fL 
3. Thorisdottir (2003) 6 to 24 months: definition: Hb<10.5g/dL + SF <10.5 µg/L+ MCV<74fL 
4. Yang (2009) 6 months: definition Hb<10.5g/dL+SF<12µg/L 
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Table 3.  Predictors of Anaemia and ID at 6 months in infants EBF for 4-5mo 
versus 6mo 
Variables Beta OR  95% CI P value R2 
adjusted 
Anaemia      0.24 
Change in WLZ 0 to 6 mo 
Delivery by Caesarean 
0.47 
1.29 
1.6 
3.7 
 1.14 to 2.24 
1.16 to 11.4 
0.007 
0.027 
 
ID      0.16 
Change in WAZ 0 to 6 mo 0.59 2.6  1.13 to 5.97 0.02  
Logistic regression models; only significant predictors are shown in the table.  
Anaemia was defined as Hb as: Hb<11g/dL. Variables entered into model were study variables: WLZ from 0 to 6mo, mode of 
delivery (0= vaginal; 1=Caesarean), mode of feeding (0=EBF 4-5, 1=EBF ≥6mo). Other variables: Birth weight (birth weight less 
than 3kg=1) sex 1=male, 0= female). Nagerlkerke R Square R=0.24 
ID was defined as SF<12µg/L. Variables entered into model were study variables: WAZ from 0 to 6mo, mode of feeding 
(0=EBF 4-5, 1=EBF ≥6mo). Other variables: mode of delivery (0= vaginal; 1=Caesarean); Birth weight (birth weight less than 
3kg=1) sex (1=male, 0= female), gestational age (number of weeks). Nagerlkerke R Square R=0.16 
 
 
 
 
 
 
 
 
 
 
